Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (S-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: Early results of a phase 2, single-arm trial - Concepedia

Concepedia

Publication | Open Access

Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (S-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: Early results of a phase 2, single-arm trial

DOI Full Paper Access

52

Citations

18

References

2022

Year

Yuping Yin, Lin Yao, Ming Yang, Jian-Bo Lv, Jiaying Liu, Ke Wu, Ke Liu, Anshu Li, Xiaoming Shuai, Kailin Cai,

Frontiers in Oncology

Abstract

https://clinicaltrials.gov/ct2/show/NCT0-4890392, identifier [NCT04890392].

References

	Year	Citations

Page 1